
### [MONDO:0005058](http://purl.obolibrary.org/obo/MONDO_0005058)
**Label:** leiomyosarcoma

**Subclasses:** [MONDO:0003928](http://purl.obolibrary.org/obo/MONDO_0003928) (uterine corpus myxoid leiomyosarcoma), [MONDO:0016283](http://purl.obolibrary.org/obo/MONDO_0016283) (leiomyosarcoma of the cervix uteri), [MONDO:0016262](http://purl.obolibrary.org/obo/MONDO_0016262) (leiomyosarcoma of the corpus uteri), [MONDO:0003349](http://purl.obolibrary.org/obo/MONDO_0003349) (central nervous system leiomyosarcoma), [MONDO:0002159](http://purl.obolibrary.org/obo/MONDO_0002159) (fallopian tube leiomyosarcoma), [MONDO:0004436](http://purl.obolibrary.org/obo/MONDO_0004436) (myxoid liposarcoma of the ovary), [MONDO:0003369](http://purl.obolibrary.org/obo/MONDO_0003369) (vagina leiomyosarcoma), [MONDO:0003347](http://purl.obolibrary.org/obo/MONDO_0003347) (inflammatory leiomyosarcoma), [MONDO:0003348](http://purl.obolibrary.org/obo/MONDO_0003348) (conventional leiomyosarcoma), [MONDO:0003367](http://purl.obolibrary.org/obo/MONDO_0003367) (gastric leiomyosarcoma (disease)), [MONDO:0003368](http://purl.obolibrary.org/obo/MONDO_0003368) (prostate leiomyosarcoma), [MONDO:0003365](http://purl.obolibrary.org/obo/MONDO_0003365) (esophagus leiomyosarcoma), [MONDO:0003364](http://purl.obolibrary.org/obo/MONDO_0003364) (gallbladder leiomyosarcoma), [MONDO:0003782](http://purl.obolibrary.org/obo/MONDO_0003782) (uterine corpus epithelioid leiomyosarcoma), [MONDO:0003362](http://purl.obolibrary.org/obo/MONDO_0003362) (cutaneous leiomyosarcoma (disease)), [MONDO:0003360](http://purl.obolibrary.org/obo/MONDO_0003360) (small intestine leiomyosarcoma), [MONDO:0013280](http://purl.obolibrary.org/obo/MONDO_0013280) (myxoid liposarcoma), [MONDO:0004207](http://purl.obolibrary.org/obo/MONDO_0004207) (pulmonary artery leiomyosarcoma), [MONDO:0004208](http://purl.obolibrary.org/obo/MONDO_0004208) (superior vena cava leiomyosarcoma), [MONDO:0003358](http://purl.obolibrary.org/obo/MONDO_0003358) (anus leiomyosarcoma), [MONDO:0004206](http://purl.obolibrary.org/obo/MONDO_0004206) (pulmonary vein leiomyosarcoma), [MONDO:0003359](http://purl.obolibrary.org/obo/MONDO_0003359) (myxoid leiomyosarcoma), [MONDO:0003356](http://purl.obolibrary.org/obo/MONDO_0003356) (epithelioid leiomyosarcoma), [MONDO:0003378](http://purl.obolibrary.org/obo/MONDO_0003378) (liver leiomyosarcoma), [MONDO:0003357](http://purl.obolibrary.org/obo/MONDO_0003357) (lung leiomyosarcoma), [MONDO:0003379](http://purl.obolibrary.org/obo/MONDO_0003379) (rectum leiomyosarcoma), [MONDO:0003376](http://purl.obolibrary.org/obo/MONDO_0003376) (mediastinum leiomyosarcoma), [MONDO:0003355](http://purl.obolibrary.org/obo/MONDO_0003355) (ovary leiomyosarcoma), [MONDO:0003377](http://purl.obolibrary.org/obo/MONDO_0003377) (extrahepatic bile duct leiomyosarcoma), [MONDO:0003374](http://purl.obolibrary.org/obo/MONDO_0003374) (larynx leiomyosarcoma), [MONDO:0003353](http://purl.obolibrary.org/obo/MONDO_0003353) (heart leiomyosarcoma), [MONDO:0003372](http://purl.obolibrary.org/obo/MONDO_0003372) (vulvar leiomyosarcoma), [MONDO:0003350](http://purl.obolibrary.org/obo/MONDO_0003350) (granular cell leiomyosarcoma), [MONDO:0003373](http://purl.obolibrary.org/obo/MONDO_0003373) (kidney leiomyosarcoma), [MONDO:0003351](http://purl.obolibrary.org/obo/MONDO_0003351) (colon leiomyosarcoma), [MONDO:0003370](http://purl.obolibrary.org/obo/MONDO_0003370) (retroperitoneal leiomyosarcoma), [MONDO:0003371](http://purl.obolibrary.org/obo/MONDO_0003371) (breast leiomyosarcoma), 

**Mapped go classes:** [GO:0036488](http://purl.obolibrary.org/obo/GO_0036488) (CHOP-C/EBP complex), [GO:0000978](http://purl.obolibrary.org/obo/GO_0000978) (RNA polymerase II proximal promoter sequence-specific DNA binding), [GO:0006355](http://purl.obolibrary.org/obo/GO_0006355) (regulation of transcription, DNA-templated), [GO:0046890](http://purl.obolibrary.org/obo/GO_0046890) (regulation of lipid biosynthetic process), [GO:0003700](http://purl.obolibrary.org/obo/GO_0003700) (DNA binding transcription factor activity), [GO:0001077](http://purl.obolibrary.org/obo/GO_0001077) (transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding), [GO:0001666](http://purl.obolibrary.org/obo/GO_0001666) (response to hypoxia), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:1990622](http://purl.obolibrary.org/obo/GO_1990622) (CHOP-ATF3 complex), [GO:0003714](http://purl.obolibrary.org/obo/GO_0003714) (transcription corepressor activity), [GO:0035976](http://purl.obolibrary.org/obo/GO_0035976) (transcription factor AP-1 complex), [GO:1990617](http://purl.obolibrary.org/obo/GO_1990617) (CHOP-ATF4 complex), [GO:0070059](http://purl.obolibrary.org/obo/GO_0070059) (intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress), 

**Class expressions from DL-Learner:**

- [GO:1990622](http://purl.obolibrary.org/obo/GO_1990622) (CHOP-ATF3 complex) 66.67%
- [GO:1990617](http://purl.obolibrary.org/obo/GO_1990617) (CHOP-ATF4 complex) 66.67%
- [GO:0036488](http://purl.obolibrary.org/obo/GO_0036488) (CHOP-C/EBP complex) 66.67%
- [GO:0043234](http://purl.obolibrary.org/obo/GO_0043234) (protein complex) 55.75%
- [GO:0090575](http://purl.obolibrary.org/obo/GO_0090575) (RNA polymerase II transcription factor complex) 55.69%
- [GO:0032991](http://purl.obolibrary.org/obo/GO_0032991) (macromolecular complex) 54.50%
- [GO:0044798](http://purl.obolibrary.org/obo/GO_0044798) (nuclear transcription factor complex) 53.75%
- [GO:0005667](http://purl.obolibrary.org/obo/GO_0005667) (transcription factor complex) 53.75%
- [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) 53.22%
- Thing 51.11%
- [GO:0044428](http://purl.obolibrary.org/obo/GO_0044428) (nuclear part) 39.21%
- [GO:0044446](http://purl.obolibrary.org/obo/GO_0044446) (intracellular organelle part) 37.30%
- [GO:0044422](http://purl.obolibrary.org/obo/GO_0044422) (organelle part) 37.10%
- [GO:0044424](http://purl.obolibrary.org/obo/GO_0044424) (intracellular part) 36.57%
- [GO:0044464](http://purl.obolibrary.org/obo/GO_0044464) (cell part) 36.14%


